0.370
0.01 (2.12%)
| Penutupan Terdahulu | 0.363 |
| Buka | 0.360 |
| Jumlah Dagangan | 306,956 |
| Purata Dagangan (3B) | 876,606 |
| Modal Pasaran | 19,383,488 |
| Harga / Pendapatan (P/E Ke hadapan) | 4.75 |
| Harga / Jualan (P/S) | 0.180 |
| Harga / Buku (P/B) | 1.05 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 16 Apr 2025 |
| Margin Keuntungan | -28.26% |
| Margin Operasi (TTM) | -6.08% |
| EPS Cair (TTM) | -1.09 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -6.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 49.51% |
| Nisbah Semasa (MRQ) | 1.05 |
| Aliran Tunai Operasi (OCF TTM) | -4.49 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.94 M |
| Pulangan Atas Aset (ROA TTM) | -14.90% |
| Pulangan Atas Ekuiti (ROE TTM) | -50.03% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Distribution (US) | Menaik | Bercampur |
| Medical Distribution (Global) | Menaik | Bercampur | |
| Stok | Cosmos Health Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.5 |
| Purata | 0.13 |
|
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment. |
|
| Sektor | Healthcare |
| Industri | Medical Distribution |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 31.08% |
| % Dimiliki oleh Institusi | 9.46% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |